These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28651185)

  • 41. A systematic review of St. John's wort for major depressive disorder.
    Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
    Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms.
    Caldieraro MA; Cassano P
    J Affect Disord; 2019 Jan; 243():262-273. PubMed ID: 30248638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis.
    Zhang ZJ; Chen HY; Yip KC; Ng R; Wong VT
    J Affect Disord; 2010 Jul; 124(1-2):9-21. PubMed ID: 19632725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
    Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-pharmacological treatment of depression: a systematic review and evidence map.
    Farah WH; Alsawas M; Mainou M; Alahdab F; Farah MH; Ahmed AT; Mohamed EA; Almasri J; Gionfriddo MR; Castaneda-Guarderas A; Mohammed K; Wang Z; Asi N; Sawchuk CN; Williams MD; Prokop LJ; Murad MH; LeBlanc A
    Evid Based Med; 2016 Dec; 21(6):214-221. PubMed ID: 27836921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Jan; 68(1):60-82. PubMed ID: 24165478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis.
    Orgeta V; Qazi A; Spector A; Orrell M
    Br J Psychiatry; 2015 Oct; 207(4):293-8. PubMed ID: 26429684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive functioning throughout the treatment history of clinical late-life depression.
    Dzierzewski JM; Potter GG; Jones RN; Rostant OS; Ayotte B; Yang FM; Sachs BC; Feldman BJ; Steffens DC
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1076-84. PubMed ID: 25703072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials.
    Kurz AF; Leucht S; Lautenschlager NT
    Int Psychogeriatr; 2011 Nov; 23(9):1364-75. PubMed ID: 21740614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restoring function in major depressive disorder: A systematic review.
    Sheehan DV; Nakagome K; Asami Y; Pappadopulos EA; Boucher M
    J Affect Disord; 2017 Jun; 215():299-313. PubMed ID: 28364701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can unipolar and bipolar pediatric major depression be differentiated from each other? A systematic review of cross-sectional studies examining differences in unipolar and bipolar depression.
    Uchida M; Serra G; Zayas L; Kenworthy T; Faraone SV; Biederman J
    J Affect Disord; 2015 May; 176():1-7. PubMed ID: 25682377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial remediation in depressive disorders: A systematic review.
    Monferrer M; Ricarte JJ; Montes MJ; Fernández-Caballero A; Fernández-Sotos P
    J Affect Disord; 2021 Jul; 290():40-51. PubMed ID: 33991945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effectiveness of non-pharmacological interventions in older adults with depressive disorders: A systematic review.
    Apóstolo J; Bobrowicz-Campos E; Rodrigues M; Castro I; Cardoso D
    Int J Nurs Stud; 2016 Jun; 58():59-70. PubMed ID: 27087298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside.
    Cai M; Wang H; Zhang X
    Adv Exp Med Biol; 2019; 1180():277-295. PubMed ID: 31784969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.
    Hausenblas HA; Heekin K; Mutchie HL; Anton S
    J Integr Med; 2015 Jul; 13(4):231-40. PubMed ID: 26165367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study.
    Greer TL; Grannemann BD; Chansard M; Karim AI; Trivedi MH
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):248-56. PubMed ID: 25453481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.